Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations

Typical Burkitt lymphoma is characterized by an IG‐MYC translocation and overall low genomic complexity. Clinically, Burkitt lymphoma has a favourable prognosis with very few relapses. However, the few patients experiencing disease progression and/or relapse have a dismal outcome. Here we report cytogenetic findings of seven cases of Burkitt lymphoma in which sequential karyotyping was performed at time of diagnosis and/or disease progression/relapse(s). After case selection, karyotype re‐review and additional molecular analyses were performed in six paediatric cases, treated in Berlin‐Frankfurt‐Münster‐Non‐Hodgkin lymphoma study group trials, and one additional adult patient. Moreover, we analysed 18 cases of Burkitt lymphoma from the Mitelman database in which sequential karyotyping was performed. Our findings show secondary karyotypes to have a significant increase in load of cytogenetic aberrations with a mean number of 2, 5 and 8 aberrations for primary, secondary and third investigations. Importantly, this increase in karyotype complexity seemed to result from recurrent secondary chromosomal changes involving mainly trisomy 21, gains of 1q and 7q, losses of 6q, 11q, 13q, and 17p. In addition, our findings indicate a linear clonal evolution to be the predominant manner of cytogenetic evolution. Our data may provide a biological framework for the dismal outcome of progressive and relapsing Burkitt lymphoma.

[1]  G. Leverger,et al.  Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective “Lymphomes Malins B” protocols. A Société Française des Cancers de l’Enfant study , 2015, Haematologica.

[2]  K. Basso,et al.  Germinal centres and B cell lymphomagenesis , 2015, Nature Reviews Immunology.

[3]  K. Ando,et al.  A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission , 2015, International Journal of Hematology.

[4]  Peter Martin,et al.  Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas , 2014, Genome Biology.

[5]  T. Liehr,et al.  Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents , 2014 .

[6]  W. Klapper,et al.  Genomic and epigenomic co-evolution in follicular lymphomas , 2014, Leukemia.

[7]  C. Bokemeyer,et al.  Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: Secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples , 2014, Genes, chromosomes & cancer.

[8]  P. Kluin The missing link in early follicular lymphoma development. , 2014, Blood.

[9]  B. Nadel,et al.  Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis? , 2014, Blood.

[10]  B. Nadel,et al.  Nature and importance of follicular lymphoma precursors , 2014, Haematologica.

[11]  O. Griffith,et al.  Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer) , 2014 .

[12]  R. Spang,et al.  Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma , 2014, Haematologica.

[13]  J. Nguyen,et al.  Analysis of Immunoglobulin Heavy Chain Rearrangement in a Child With Recurrent Burkitt Lymphoma to Determine Clonality , 2014, Journal of pediatric hematology/oncology.

[14]  Raul Rabadan,et al.  Genetics of follicular lymphoma transformation. , 2014, Cell reports.

[15]  M. Calaminici,et al.  Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma , 2013, Nature Genetics.

[16]  Raul Rabadan,et al.  Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. , 2013, Blood.

[17]  F. Mitelman,et al.  Mitelman database of chromosome aberrations and gene fusions in cancer , 2014 .

[18]  S. Carter,et al.  Clonal evolution in hematological malignancies and therapeutic implications , 2014, Leukemia.

[19]  E. Kjeldsen,et al.  Supernumerary Isochromosome 1, idic(1)(p12), Leading to Tetrasomy 1q in Burkitt Lymphoma , 2013, Cytogenetic and Genome Research.

[20]  Raffaella Casadei,et al.  An estimation of the number of cells in the human body , 2013, Annals of human biology.

[21]  Krishnendu Chatterjee,et al.  Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.

[22]  W. Woessmann XI. How to treat children and adolescents with relapsed non‐Hodgkin lymphoma? , 2013, Hematological oncology.

[23]  S. Swerdlow,et al.  Double-hit B-cell Lymphomas With BCL6 and MYC Translocations Are Aggressive, Frequently Extranodal Lymphomas Distinct From BCL2 Double-hit B-cell Lymphomas , 2013, The American journal of surgical pathology.

[24]  Giovanni Parmigiani,et al.  Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.

[25]  A. Hagemeijer,et al.  Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B‐cell lymphomas with MYC rearrangement , 2013, Genes, chromosomes & cancer.

[26]  Ash A. Alizadeh,et al.  Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. , 2012, Blood.

[27]  R. Spang,et al.  Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.

[28]  Dereje D. Jima,et al.  The genetic landscape of mutations in Burkitt lymphoma , 2012, Nature Genetics.

[29]  L. Staudt,et al.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics , 2012, Nature.

[30]  M. Nussenzweig,et al.  Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. , 2012, Blood.

[31]  Michael Meyer-Hermann,et al.  A theory of germinal center B cell selection, division, and exit. , 2012, Cell reports.

[32]  R. Miles,et al.  Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia , 2012, British journal of haematology.

[33]  D. Linch,et al.  Burkitt lymphoma in adults , 2012, British journal of haematology.

[34]  R. Siebert,et al.  The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  P. Krapivsky,et al.  Exact solution of a two-type branching process: models of tumor progression , 2011, 1105.1157.

[36]  A. Cherry,et al.  A pediatric B lineage leukemia with coincident MYC and MLL translocations. , 2011, Journal of pediatric hematology/oncology.

[37]  Philip M Kluin,et al.  Double-hit B-cell lymphomas. , 2011, Blood.

[38]  W. Klapper,et al.  Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols , 2011, Leukemia.

[39]  R. Spang,et al.  Detection of genomic aberrations in molecularly defined Burkitt’s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis , 2010, Haematologica.

[40]  T. Wirth,et al.  Advances in the understanding of MYC‐induced lymphomagenesis , 2010, British journal of haematology.

[41]  N. Karandikar,et al.  Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas , 2010, Modern Pathology.

[42]  R. Durrett,et al.  Evolutionary dynamics of tumor progression with random fitness values. , 2010, Theoretical population biology.

[43]  W. Sanger,et al.  An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG‐5961 , 2010, British journal of haematology.

[44]  H. Ohtsuki,et al.  Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.

[45]  G. Klein,et al.  To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes. , 2009, Seminars in cancer biology.

[46]  R. Gascoyne,et al.  Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. , 2009, Blood.

[47]  W. Sanger,et al.  Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell Non-Hodgkin’s Lymphoma: Results of the FAB/LMB 96 international study , 2008, Leukemia.

[48]  R. Siebert,et al.  Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.

[49]  G. Klein,et al.  Burkitt lymphoma. , 2005, Seminars in cancer biology.

[50]  Myungshin Kim,et al.  Burkitt lymphoma with dual translocation of chromosome 14: a novel chromosomal abnormality of t(8;14),t(14;15). , 2008, Annals of clinical and laboratory science.

[51]  Carolyn J. Brown,et al.  Prognostic significance of secondary cytogenetic alterations in follicular lymphomas , 2008, Genes, chromosomes & cancer.

[52]  H. Avet-Loiseau Reply to: [Comment to: The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342 , 2008, Haematologica.

[53]  H. Tilly,et al.  Comment to: The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342 , 2008, Haematologica.

[54]  A. Rosenwald,et al.  Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma , 2008, Oncogene.

[55]  Riccardo Dalla-Favera,et al.  Germinal centres: role in B-cell physiology and malignancy , 2008, Nature Reviews Immunology.

[56]  Å. Borg,et al.  Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3. , 2007, Human molecular genetics.

[57]  C. Larsson,et al.  Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma , 2007, Modern Pathology.

[58]  S. Raimondi,et al.  Secondary chromosomal abnormalities predict outcome in pediatric and adult high‐stage Burkitt lymphoma , 2006, Cancer.

[59]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[60]  B. Burkhardt,et al.  The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence , 2005, British journal of haematology.

[61]  Bernhard Hiller,et al.  CyDAS: a cytogenetic data analysis system , 2005, Bioinform..

[62]  J. Walewski,et al.  Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma. , 2005, Cancer genetics and cytogenetics.

[63]  P. Jagers,et al.  Branching Processes: Variation, Growth, and Extinction of Populations , 2005 .

[64]  P. Kluin,et al.  Gender and age-related differences in Burkitt lymphoma--epidemiological and clinical data from The Netherlands. , 2004, European journal of cancer.

[65]  W. Sanger,et al.  Chromosome Abnormalities May Correlate With Prognosis in Burkitt/Burkitt-Like Lymphomas of Children and Adolescents: A Report From Children's Cancer Group Study CCG-E08 , 2004, Journal of pediatric hematology/oncology.

[66]  C. Morris,et al.  Telomeric association of chromosomes in B-cell lymphoid leukemia , 2004, Human Genetics.

[67]  A. Borkhardt,et al.  Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. , 2004, Haematologica.

[68]  Shumei S. Guo,et al.  2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.

[69]  Martin J S Dyer,et al.  Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci , 2002, International journal of cancer.

[70]  B. Johansson,et al.  Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia , 2002, Acta Haematologica.

[71]  Shumei S. Guo,et al.  CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000 , 2002 .

[72]  Marek Kimmel,et al.  Branching processes in biology , 2002 .

[73]  G. Leverger,et al.  Francaise d ' Oncologie Pediatrique LMB 89 protocol : highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L 3 leukemia , 2001 .

[74]  C. R. Pinkerton,et al.  Outcome of relapsed or refractory childhood B‐cell acute lymphoblastic leukaemia and B‐cell non‐Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols , 2001, British journal of haematology.

[75]  Garnett Kelsoe,et al.  Predicted and inferred waiting times for key mutations in the germinal centre reaction: Evidence for stochasticity in selection , 1998, Immunology and cell biology.

[76]  M. Narbaitz,et al.  Variant (8;22) translocation in lymphoblastic lymphoma. , 1996, Leukemia & lymphoma.

[77]  M. Fussenegger,et al.  Cloning and characterization of the , 1996 .

[78]  B. Johansson,et al.  Cytogenetic evolution patterns in non-Hodgkin's lymphoma. , 1995, Blood.

[79]  H. Kantarjian,et al.  Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes , 1995, Cancer.

[80]  J. Goedert,et al.  Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[81]  S. Steinberg,et al.  Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. , 1995, Blood.

[82]  J. M. García-Sagredo,et al.  Burkitt lymphoma with a duplication of der(8)t(2;8). Interpretation of a complex karyotype by chromosome painting. , 1994, Cancer genetics and cytogenetics.

[83]  H. Naito,et al.  Jumping translocations of 1q in Burkitt lymphoma and acute nonlymphocytic leukemia. , 1993, Cancer genetics and cytogenetics.

[84]  N. Heerema,et al.  Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia. , 1992, Leukemia.

[85]  D. de Jong,et al.  Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. , 1991, Oncogene.

[86]  T. Takeda,et al.  Karyotypic changes from initial diagnosis to relapse in childhood acute leukemia. , 1990, Leukemia.

[87]  R. Berger,et al.  Secondary nonrandom chromosomal abnormalities of band 13q34 in burkitt lymphoma‐leukemia , 1989, Genes, chromosomes & cancer.

[88]  P. Fenaux,et al.  Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities. , 1989, Annales de genetique.

[89]  E. Jaffe,et al.  Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient. , 1988, Blood.

[90]  G. Tricot,et al.  Burkitt-type ALL with variant t(2;8) and complex additional rearrangements at diagnosis. , 1987, Annales de Genetique.

[91]  K. Franssila,et al.  Chromosome abnormalities in 16 Finnish patients with Burkitt's lymphoma or L3 acute lymphocytic leukemia. , 1984, Cancer genetics and cytogenetics.

[92]  H. Ohno,et al.  Karyotype evolution in B‐cell lymphoid malignancy with AN 8;14 translocation , 1983, International journal of cancer.

[93]  R. Berger,et al.  Cytogenetic studies on Burkitt's lymphoma-leukemia. , 1982, Cancer genetics and cytogenetics.

[94]  E. Gelmann,et al.  Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[95]  Y. Hayashi,et al.  Burkitt's lymphoma with 2/8 translocation: a case report with special reference to the clinical features. , 1982, Cancer genetics and cytogenetics.

[96]  L. Zech,et al.  High‐resolution analysis of chromosome markers in burkitt lymphoma cell lines , 1982, International journal of cancer.

[97]  K. Woo,et al.  ANALYSIS OF THE PROLIFERATION KINETICS OF BURKITT'S LYMPHOMA CELLS , 1980, Cell and tissue kinetics.

[98]  J. Whang‐Peng,et al.  Cytogenetic studies in non-African Burkitt lymphoma. , 1980, Blood.

[99]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .

[100]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[101]  W. J. Harrison The total cellularity of the bone marrow in man , 1962, Journal of clinical pathology.